The 28th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Print

Oral Session

[OR3] Oral Session Ⅲ Cancer②

Thu. Jul 14, 2022 3:30 PM - 4:42 PM Room 3 (3F 304)

Chair persons : Shuji Kubo（Laboratory of Molecular and Genetic Therapeutics, Institute for Advanced Medical Sciences, Hyogo College of Medicine）,Hajime Kurosaki（Division of Molecular Medicine, Department of Genomic Medicine and Regenerative Therapeutics, School of Medicine, Tottori University Faculty of Medicine）

[OR-23] Novel armed oncolytic HSV exhibits strong antitumor effects that lead to complete tumor regression

Mohamed Abdelmoneim (Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University,Nagoya, Japan / Department of Surgery II, Graduate School of Medicine, Nagoya University,Nagoya, Japan / Department of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt)

Abstract password authentication.
The password was sent to all registrants in email. You can also check it in abstracts and a live streamig site.

Password